• en
  • fr

  • Education and advocacy to tackle antibiotic resistance

    Global Point Prevalence Survey

    Global Point Prevalence Survey

    GlobalPPSThe Global Point Prevalence Survey (GLOBAL-PPS) is a study uniquely supported by bioMérieux, which originated at the 4th World HAI/Resistance Forum World HAI/Resistance Forum in 2013. The Global-PPS was launched in 2014 and was designed to provide a global "snapshot" of antibiotic use and resistance in hospitals.The GLOBAL-PPS has been endorsed by WHO, CDDEP, IDSA and GARP.

    Watch the video of the Global-PPS

    Unprecedented in scope, it is coordinated by the University of Antwerp Hospital (Belgium) and a group of experts including Professors Herman Goossens, Dilip Nathwani, Vincent Jarlier and Peter Zarb, who have already conducted studies of this kind. In the first edition in 2015, it included 100,000 patients and mobilized more than 335 hospital centers in more than 53 countries across all continents. The information obtained will be used to create a global database dedicated to antibiotic consumption and resistance in hospital settings. The results of the survey were presented during ECCMID 2016.(24)

    Following the valuable insights obtained through the first GLOBAL-PPS, bioMérieux renewed its support for a second edition of this survey in 2017,  which places more emphasis on education and on low- and middle-income countries (LMIC), which frequently have high antimicrobial prescription rates and resistance levels, yet have no access to surveillance networks. With more than 51 countries now represented, the GLOBAL-PPS offers educational tools, in particular a PPS e-learning tool developed by the British Society for Antimicrobial Chemotherapy with bioMérieux’s support. This training module, associated with other tools, will help hospitals develop and implement customized action plans based on their Global-PPS results and local priorities.

    ⇒ Read updates on the GLOBAL-PPS in AMR Control 2017, co-authored by bioMérieux.

    ⇒ Read our case study on the GLOBAL-PPS on the AMR Industry Alliance website, bioMérieux being a member of the Alliance.

    ⇒ Discover the latest results, published in the journal Lancet Global Health: Lancet Global Health Main Article GLOBAL-PPS

    N.B.: bioMérieux, as part of its global commitment to surveillance and stewardship, is the sole sponsor of the GLOBAL-PPS and E-learning PPS. bioMérieux has no role in study design, data collection, data analysis, data interpretation, or writing the report. Data are strictly confidential and stored anonymously at the coordinating centre of the University of Antwerp, Belgium.